Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure

Background: In patients with heart failure (HF), discontinued medical therapy because of adverse events (AE) is associated with high mortality. Patients with type 2 diabetes mellitus (T2DM) treated with sodium-glucose co-transporter 2 inhibitors (SGLT2i) have a lower risk of HF, but AE sometimes occ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Rep
Autors principals: Yazaki, Mayu, Nabeta, Takeru, Inomata, Takayuki, Maemura, Kenji, Ooki, Takumi, Fujita, Teppei, Iida, Yuichiro, Ikeda, Yuki, Ishii, Shunsuke, Naruke, Takashi, Ako, Junya
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Circulation Society 2019
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929704/
https://ncbi.nlm.nih.gov/pubmed/33693174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0080
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars